FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b) Owner or controller of
RNS Number : 3407U Stifel Nicolaus Europe Limited 28 June 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of
RNS Number : 2377U Renalytix PLC 28 June 2024 Renalytix plc ("Renalytix" or the "Company") Total Voting Rights LONDON and NEW YORK , 28 June 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that at today's date, the Company's total issued share capital is 154,368,191
RNS Number : 2544U Renalytix PLC 28 June 2024 This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR").
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b) Owner or controller of
RNS Number : 1380U Stifel Nicolaus Europe Limited 27 June 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b) Owner or controller of
RNS Number : 9611T Stifel Nicolaus Europe Limited 26 June 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of
RNS Number : 7650T Stifel Nicolaus Europe Limited 25 June 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of
RNS Number : 6900T Renalytix PLC 25 June 2024 Renalytix plc ("Renalytix" or the "Company") Change of public accounting firm LONDON and NEW YORK , 25 June 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces the appointment of CohnReznick LLP as the Company's US independent
